Better Context → Better Decisions
Context counts in life sciences. The FENIX analyst team is tirelessly using its experience to put you in a position to succeed. Below, our readers with corporate access will find a wealth of contextualized life science insight ready to be viewed in the FENIX Marketplace.
Welcome to FENIX Syndicated Services. If you already have an account, please log in. If you have any questions or would like to subscribe to our services, please contact us.
$599
Posted in: Basal Insulin Dec 07 | 2020Novo Retracts CONCLUDE (H2H Tresiba vs. Toujeo) Press ReleasePurchase Blast$599
Posted in: GLP-1RA Dec 04 | 2020Novo Files Sema 2.4mg Obesity Indication with FDAPurchase Blast
$599
Posted in: Glucose Monitoring Dec 03 | 2020Libre 2 Appears to Remain in US Soft Launch; When will Broad Launch Commence?Purchase Blast
$599
Posted in: Other Nov 30 | 2020Pharmaceutical Strategies Group Launches "Total Cost of Diabetes Care" Feature for Health Plans and EmployersPurchase Blast
$599
Posted in: Other Nov 24 | 2020Summary of Novartis Meet the Management Investor EventPurchase Blast
$599
Posted in: Basal Insulin, Glucose Monitoring, Insulin Delivery Nov 24 | 2020Medtronic CY Q3 ’20 (FY Q2 ’21) Earnings Update; Dario Signs New Deal with Fortune 500 Company; Oramed Screens First Patients in the Ph3 ORMD-0801 TrialPurchase Blast
$599
Posted in: Other Nov 23 | 2020Amgen Returns Omecamtiv Rights to Cytokinetics; Risk-reward for CYTK Hinges on FDA AdcomPurchase Blast
$599
Posted in: Other Nov 20 | 2020Imeglimin Ph3 US and EU Development Discontinued by Metavant; Poxel Seeks Other OptionsPurchase Blast
$599
Posted in: Insulin Delivery Nov 19 | 2020Lilly Partners with Ypsomed for AID System; Tidepool Lays Off 40% of StaffPurchase Blast
$599
Posted in: SGLT2i Nov 18 | 2020Lexicon @ Stifel; First Presentation Since SOLOIST and SCORED ResultsPurchase Blast
$599
Posted in: Glucose Monitoring, SGLT2i Nov 18 | 2020EMPA-REG OUTCOME Post Hoc Analysis; Abbott Sponsors ADA Health Equity Initiative; Nemaura Launches BEAT Platform and Updated Company Website Ahead of US proBEAT LaunchPurchase Blast
$599
Posted in: GLP-1RA Nov 17 | 2020SUSTAIN FORTE Topline Results: Ozempic 2.0mg Doubles the Dose but not the EfficacyPurchase Blast
$599
Posted in: GLP-1RA, Glucose Monitoring, Insulin Delivery, Other Nov 16 | 2020FDA Accepts IND for Lilly/Dicerna Cardiometabolic Asset; Gilead/Novo Announce Ph2 PoC NASH Results; Biocorp Launches Mallya in Europe; Nemaura Q3 '20 Earnings Update; Diabeloop Partners for AID System in JapanPurchase Blast
$599
Posted in: Other Nov 13 | 2020Omecamtiv Misses on Primary Outcome Components, Hits on LVEF <28% Subgroup; GALACTIC-HF @ AHA 2020Purchase Blast
$599
Posted in: Glucagon, Glucose Monitoring Nov 12 | 2020Zealand and Dario Q3 '20 Earnings Updates; Tidepool Completes Loop Human Factors Validation StudyPurchase Blast
$599
Posted in: Glucose Monitoring, Insulin Delivery Nov 12 | 2020Medtronic Launches InPen with Integrated Guardian ConnectPurchase Blast